Analysis of 18 F-FDG PET Mapping in Malignant Tumor Patients with Depression by SPM

苏亮,左传涛,管一晖,赵军,施慎逊
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2005.03.012
2005-01-01
Abstract:Objective To investigate brain 18F-fluorodeoxyglucose (FDG) PET mapping in malignant tumor patients with depressive emotion. Methods 18F-FDG PET imaging was performed in 21 malignant tumor patients (tumor group) and 21 healthy controls (control group). All were evaluated by self-rating depression scale(SDS)and 24 questions Hamilton rating scale for depression (HAMD). Results ①The standard total score of SDS and HAMD of the tumor group were higher than those of the control group (P0.05). Retardation, anxiety/somatization, weight loss, sleep disorder and feeling of despair etc, 5 factor scores of HAMD in the tumor group were higher than those of the control group (P0.05). The other two factor scores were not statistically different. ②Statistical parametric mapping (SPM2) analysis: compared with the control group, regional cerebral glucose metabolism rates in left inferior temporal gyrus, superior temporal gyrus, posterior cingulate gyrus, middle temporal gyrus, angular gyrus, cuneus and right anterior cingulate gyrus, middle frontal gyrus and bilateral inferior frontal gyrus in the tumor group decreased. These results were in accordance with previous PET studies on major depression disorders. Conclusions Malignant tumor patients with depressive emotion revealed glucose hypometabolism in some brain regions of 18F-FDG PET imagings. The abnormalities of glucose metabolism might be related to their depressive emotion.
What problem does this paper attempt to address?